These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6365832)

  • 21. Type I diabetes. Control with individualized insulin regimens.
    Spencer M
    Postgrad Med; 1989 Mar; 85(4):201-9. PubMed ID: 2648355
    [No Abstract]   [Full Text] [Related]  

  • 22. [Intensified insulin therapy in children and adolescents with labile diabetes mellitus].
    Lebedev NB; Shcherbacheva LN; Kniazeva AP; Lobanova AM
    Pediatriia; 1989; (11):75-9. PubMed ID: 2691980
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of administration of Human Monocomponent insulin (HM) on lipodystrophies in children].
    Domagała L
    Wiad Lek; 1988 Nov; 41(21):1471-3. PubMed ID: 3074583
    [No Abstract]   [Full Text] [Related]  

  • 24. Mixing insulin lispro and ultralente insulin.
    Bastyr EJ; Holcombe JH; Anderson JH; Clore JN
    Diabetes Care; 1997 Jun; 20(6):1047-8. PubMed ID: 9167130
    [No Abstract]   [Full Text] [Related]  

  • 25. Human insulin and porcine insulin in the treatment of diabetic children: comparison of metabolic control and insulin antibody production.
    Mann NP; Johnston DI; Reeves WG; Murphy MA
    Br Med J (Clin Res Ed); 1983 Nov; 287(6405):1580-2. PubMed ID: 6416511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin degludec: The new standard long acting insulin analogue for people with type 1 diabetes? [Letter to the Editor].
    Merchante-Alfaro AÁ; Pérez-Naranjo S; Abellán-Galiana P; Rubio-Puchol O
    Endocr J; 2016 Apr; 63(4):411-2. PubMed ID: 26961339
    [No Abstract]   [Full Text] [Related]  

  • 27. Successful treatment of unusual case of brittle diabetes with sulfated beef insulin.
    Davidson MB; Kumar D; Smith W
    Diabetes Care; 1991 Nov; 14(11):1109-10. PubMed ID: 1797500
    [No Abstract]   [Full Text] [Related]  

  • 28. Insulin detemir (levemir), a new long-acting insulin.
    Med Lett Drugs Ther; 2006 Jul; 48(1238):54-5. PubMed ID: 16841022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transfer from purified porcine insulins to semisynthetic human insulins decreases insulin antibodies and circulating immune complexes in diabetic children and adolescents. A two-year follow-up.
    Dorchy H; Duchateau J; Bosson D; D'Hooge D
    Diabete Metab; 1989; 15(3):107-10. PubMed ID: 2668052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The management of brittle diabetes mellitus in children.
    Rosenbloom AL
    South Med J; 1971 Jun; 64(6):729-33. PubMed ID: 4996757
    [No Abstract]   [Full Text] [Related]  

  • 31. A simple and rational twice daily insulin regime. Distinction between basal and meal insulin requirements.
    Phillips M; Simpson RW; Holman RR; Turner RC
    Q J Med; 1979 Jul; 48(191):493-506. PubMed ID: 396545
    [No Abstract]   [Full Text] [Related]  

  • 32. Human ultralente insulin: a comparison with porcine lente insulin as a twice-daily insulin in insulin-dependent diabetic patients with fasting hyperglycaemia.
    Francis AJ; Hanning I; Alberti KG
    Diabetes Res; 1986 Jun; 3(5):263-8. PubMed ID: 3527523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term efficacy of semi-synthetic human insulins (SHI) in newly-diagnosed insulin-dependent diabetic patients. A two year clinical study.
    De Leeuw I; Van Gaal L; Nobels F; Bekaert J
    Acta Clin Belg; 1986; 41(6):381-7. PubMed ID: 3554867
    [No Abstract]   [Full Text] [Related]  

  • 34. Hazards of inaccurate readings obtained by self-monitoring of blood glucose.
    Beu DS
    Diabetes Care; 1990 Nov; 13(11):1131-2. PubMed ID: 2261829
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevention of early-morning hyperglycemia in IDDM patients with long-acting zinc insulin.
    Parillo M; Mura A; Iovine C; Rivellese AA; Lavicoli M; Riccardi G
    Diabetes Care; 1992 Feb; 15(2):173-7. PubMed ID: 1547673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Activity of varous prolonged action insulins in diabetes in children].
    Nowak S; Planeta-Malecka I; Margolis A; Olszowska L; Krzemieniowa I
    Pediatr Pol; 1968 May; 43(5):585-92. PubMed ID: 4875943
    [No Abstract]   [Full Text] [Related]  

  • 37. [Association of zinc-mixed insulin with a new rapid acting ordinary insulin. Experimental study in the treatment of infantile diabetes].
    Chaptal J; Jean R; Gillaumot R; Morel G
    Pathol Biol; 1965; 13(11):622-9. PubMed ID: 5321079
    [No Abstract]   [Full Text] [Related]  

  • 38. [Immunogenicity of MC Lente Novo insulin].
    Rogala H; Lawecki J; Czyzyk A
    Pol Arch Med Wewn; 1986 Sep; 76(3):172-6. PubMed ID: 3554163
    [No Abstract]   [Full Text] [Related]  

  • 39. Roles of site and timing of the morning insulin injection in type 1 diabetes.
    Witt MF; White NH; Santiago JV
    J Pediatr; 1983 Oct; 103(4):528-33. PubMed ID: 6352884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction in insulin antibodies 42 months after transfer from porcine to human monocomponent insulins.
    Virgili F; Frigato F; Magnanini PG; Coronel GA; Iavicoli M
    Diabetes Res; 1988 Sep; 9(1):19-20. PubMed ID: 3071441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.